NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

乾癬:競爭情形 (2020年)

Psoriasis - Competitive Landscape in 2020

出版商 GlobalData 商品編碼 995614
出版日期 內容資訊 英文 59 Pages
訂單完成後即時交付
價格
乾癬:競爭情形 (2020年) Psoriasis - Competitive Landscape in 2020
出版日期: 2020年12月31日內容資訊: 英文 59 Pages
簡介

乾癬治療藥的開發平台醫藥品,現在有350種產品在臨床實驗中,有89%在臨床實驗的初期階段。高額的治療藥的追加認證預期是市場主要促進因素,另外生物相似藥的出現也有可能妨礙市場成長。

本報告提供乾癬治療藥的開發、上市趨勢預測相關分析,目前治療環境,及主要成藥、開發平台醫藥品的概要,臨床實驗的進展,各種產品的上市可能性,社群媒體和數位行銷的活用狀況,主要企業的產品開發、策略展開的動向等資訊彙整,為您概述為以下內容。

目錄

第1章 目錄

第2章 摘要整理

第3章 簡介

  • 分析範圍
  • 流行病學概要
  • 流行病學

第4章 成藥的評估

  • 成藥概要
  • 成藥的簡介

第5章 開發平台醫藥品的評估

  • 開發平台醫藥品概要
  • 開發平台醫藥品:各地區的明細
  • 開發平台醫藥品:各分子類型、各標的的明細
  • 優先的審查的指定的可能性
  • 相變的成功率
  • 核準的可能性

第6章 臨床實驗的評估

  • 臨床實驗概要:各相 (各期)
  • 各地區的概要
  • 各治療領域的展望
  • 主要贊助商 (資金提供者)
  • 登記情形分析
  • 實行可能性分析

第7章 商業性評估

  • 今後的市場促進因素

第8章 社群媒體與數位行銷

  • Twitter的有力Chatter
  • 知名品牌藥企業的網站
  • 信任來源和引用來源

第9章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC035CL

GlobalData's "Psoriasis - Competitive Landscape in 2020" combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Interleukin and tumor necrosis factor inhibitors are the major focus of drug developers. There are 350 drugs in the pipeline, 89% 0f which are in early-stage. Big pharma dominates R&D in this indication. Addition of several high-priced therapies are expected to drive the market growth, but emergence of biosimilars to all the marketed brands is expected to act as a strong barrier to market growth.

This reports provides a data-driven overview of the current and future competitive landscape in Psoriasis therapeutics.

Scope

Components of the report include -

  • Disease epidemiology
  • Marketed drugs assessment
  • Pipeline drugs assessment
  • Clinical trials assessment
  • Commercial assessment
  • Social media overview
  • Digital marketing overview

Reasons to Buy

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global psoriasis market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global psoriasis in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

1.Table of Contents

  • 1.1 Preface
  • 1.2 Abbreviations
  • 1.3 Related Reports
  • 1.4 Upcoming Related Reports

2 Executive Summary

  • 2.1 Key Findings
  • 2.2 Key Events

3 Introduction

  • 3.1 Report Scope
  • 3.2 Disease Overview Epidemiology Overview
  • 3.3 Epidemiology

4 Marketed Drugs Assessment

  • 4.1 Marketed Drugs Overview
  • 4.2 Marketed Drug Profiles

5 Pipeline Assessment

  • 5.1 Pipeline Overview
  • 5.2 Pipeline Breakdown by Region
  • 5.3 Pipeline Breakdown by Molecule Type and Target
  • 5.4 Drug Review Designations
  • 5.5 Phase Transition Success Rates
  • 5.6 Likelihood of Approval

6 Clinical Trial Assessment

  • 6.1 Clinical Trials Overview by Phase
  • 6.2 Overview by Region
  • 6.4 Therapy Area Perspective
  • 6.4 Leading Sponsors
  • 6.5 Enrollment Analytics
  • 6.6 Feasibility Analysis

7 Commercial Assessment

  • 7.1 Upcoming Market Catalysts

8 Social Media and Digital Marketing

  • 8.1 Key Twitter Chatter
  • 8.2 Top Branded Websites
  • 8.3 Trust Flow and Citation Flow

9 Appendix

  • 9.1 Methodology
  • 9.2 About the Authors
  • 9.3 About GlobalData
  • 9.4 Contact Us
  • 9.5 Disclaimer